Product Information
DEXTROAMP-AMPHET ER 10 MG CAP is a generic product labeled by Sandoz Inc., priced at $0.5367 per EA under NDC 00781233501. Its NADAC has been published 467 times since Oct 12, 2016.
FDA first approved this application on Oct 11, 2001. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
DEXTROAMP-AMPHET ER 10 MG CAP
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATEStrength
2.5; 2.5; 2.5; 2.5 mg/1; mg/1; mg/1; mg/1
Manufacturer
Sandoz Inc.NDC
00781233501
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021303FDA Approved
10/11/2001
TE Code
AB1
On Market Since
4/2/2009
Pharmacological Classes
Price Statistics
The NADAC for DEXTROAMP-AMPHET ER 10 MG CAP has been published 467 times since Oct 12, 2016, and over the history we have for it it has declined 82.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5367 per EA |
|---|---|
| All-time high | $3.1198 (Oct 12, 2016) |
| All-time low | $0.3703 (Jul 17, 2024) |
| 52-week high | $0.6088 |
| 52-week low | $0.5367 |
| Median price | $0.7045 |
| Average price | $1.2513 |
| Largest weekly change | +63.7% (Aug 21, 2024) |
| Weeks tracked | 467 |
| Tracking since | Oct 12, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-11.8%
3Y
-7.1%
5Y
-22.2%
All
-82.8%
Last surveyed Sep 17, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DEXTROAMP-AMPHET ER 10 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHET ER 10 MG CAP, manufactured by Sandoz Inc., is $0.5367 per EA (NDC 00781233501), effective Sep 17, 2025.
How has the price of DEXTROAMP-AMPHET ER 10 MG CAP changed over time?
Over the history we have for it, the NADAC for DEXTROAMP-AMPHET ER 10 MG CAP has declined 82.8%. It has been tracked across 467 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHET ER 10 MG CAP?
Since Oct 12, 2016, the NADAC for DEXTROAMP-AMPHET ER 10 MG CAP has ranged from a low of $0.3703 (Jul 17, 2024) to a high of $3.1198 (Oct 12, 2016), with a median of $0.7045 per EA.
Are there cheaper alternatives to DEXTROAMP-AMPHET ER 10 MG CAP?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DEXTROAMP-AMPHET ER 10 MG CAP, is $0.5272 per EA — about 2% below DEXTROAMP-AMPHET ER 10 MG CAP.
Who manufactures DEXTROAMP-AMPHET ER 10 MG CAP?
DEXTROAMP-AMPHET ER 10 MG CAP (NDC 00781233501) is labeled by Sandoz Inc., and CMS classifies it as a generic product.